Search results
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 6 days agoA deputy was calling with good news: The company’s new, experimental drug tirzepatide not only cut...
Gateway - Quartz
Quartz· 14 hours agoDenmark’s prime minister, Mette Frederiksen, called the Ozempic “fantastic” and said she was “huge fan” at a parliamentary debate. People who depend on daily insulin shots may soon have welcome ...
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity ...
Motley Fool via Yahoo Finance· 5 days ago/Mounjaro could achieve greater weight loss. This efficacy advantage could enable Lilly's weight-...
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It
Motley Fool via Yahoo Finance· 4 days agoIt was a phase-one trial but an encouraging one nonetheless. AstraZeneca has shown interest in the...
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Motley Fool via Yahoo Finance· 4 days agoAlpine's porvetacicept should advance into phase 3 testing for treating the rare kidney disease IgA...
Takeda drug for rare types of epilepsy misses goal in late-stage trial
BioPharma Dive via Yahoo Finance· 2 days agoCalled soticlestat, the drug had seemed promising in earlier studies for people with Dravet and...
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
Motley Fool via Yahoo Finance· 2 days agoThe biggest story for Viking was its announcement in late February of results from a phase 2 study...
Tang Prize in Biopharmaceutical Science Honoring Three Scientists
Morningstar· 12 hours agoTAIPEI, June 19, 2024 /PRNewswire/ -- In a continuing series of laureate announcements, the Tang Prize Foundation today (June 19th) announced the 2024 Tang Prize in Biopharmaceutical Science recipients. The prestigious award has been jointly awarded
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 2 days agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...
